Clinical Trial Update: Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study of adipiplon vs placebo and an active control in adults with primary insomnia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Active Control
• Adipiplon (adipiplon)

Snippet

Sponsor: Neurogen Corporation | Conditions: Primary Insomnia | Phase 2 | Status: TERMINATED